Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MRAS |
| Upstream (Parents) |
|---|
| (<<) PHF20L1 → MRAS |
| (<<) CSH2 → MRAS |
| (<<) RYR3 → MRAS |
| (<<) ALOXE3 → MRAS |
| (<<) CD52 → MRAS |
| (<<) INHBA → MRAS |
| (<<) SOAT2 → MRAS |
| (<<) SCT → MRAS |
| (<<) NPPB → MRAS |
| (<<) LAIR1 → MRAS |
| (<<) PLCL1 → MRAS |
| Downstream (Children) |
|---|
| MRAS → PHF20L1 (>>) |
| MRAS → SEMA3E (>>) |
| MRAS → ALOXE3 (>>) |
| MRAS → PNLIPRP1 (>>) |
| MRAS → SOAT2 (>>) |
| MRAS → CA6 (>>) |
